Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XLF vs GSK✓SelectedUSD · GSKXLF vs GSK performance historyLatest closeAs of-1.49%11/19
Stock and ETF performance explorer

XLF vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+9.5%
GSK return
+5.3%
Excess return
+4.2%
Maximum drawdown
-14.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.5%-1.6%+0.1%-1.2%
7D-4.5%-4.7%+0.2%-3.7%
30D-0.3%-4.7%+4.4%+0.5%
3M-3.0%-8.8%+5.8%-1.5%
6M+9.5%-4.6%+14.2%+10.2%
YTD+2.7%+1.0%+1.7%+1.4%
1Y+9.5%+6.9%+2.6%+5.8%
All+9.5%+5.3%+4.2%+5.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling